Young Adults' Reactions to Low Nicotine Cigarette Advertising - Trial NCT04906148
Access comprehensive clinical trial information for NCT04906148 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Recruiting. The study focuses on Smoking. Target enrollment is 340 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Pennsylvania
Timeline & Enrollment
N/A
May 27, 2021
Dec 15, 2022
Primary Outcome
Attention,Risk beliefs,Recall,Perceived health risks
Summary
Reducing the nicotine content in combustible cigarettes to non-addictive levels has
 demonstrated promise as a safe and effective public health strategy for decreasing
 tobacco-caused morbidity and mortality. Little data are available, however, assessing how the
 marketing of low nicotine content (LNC) cigarettes could dampen their potential population
 health benefit. This study will examine LNC cigarette advertising content effects on message
 recall, viewing patterns, product perceptions, and use behaviors. Young adults (N = 340; 170
 smokers, 170 non-smokers) will complete a single-session laboratory study using a 2 x 2
 between-subject design to manipulate advertisement messaging accuracy (true vs.
 false/misleading) and content (implicit vs. explicit). Findings may be used to guide public
 health policy decisions related to regulating cigarette nicotine content and marketing.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04906148
Non-Device Trial